ELAVL1 and breast carcinoma: In this study we investigated the role of the protein HuR during the cellular response to the chemotherapeutic agent doxo, demonstrating its involvement in doxo-induced apoptosis and in the onset of in vitro resistance to this drug in breast cancer cells.